DZS Clinical Services announced today that SBI Pharmaceuticals, the leading expert in research, development, and manufacturing of 5-ALA, has entered into a preferred provider agreement with DZS to manage several clinical programs related to the development of 5-ALA. Bound Brook, NJ (PRWEB) July 24, 2014 As part of the long-term strategic approach, DZS expects to […]
This Week We’re Talking About: Biopharma’s challenges, Big Pharma, and Indian Clinical Trials
Challenges for biopharmas, big pharma and Indian clinical trials lead our list of hot topics this week! 1. Timescales and sourcing comparator biologics are the biggest challenges for biopharmas running biosimilars studies. 2. After much resistance, some big pharma companies are allowing a look at their clinical trials and patient information in order to further research and […]
This Week We’re Talking About: Industry Careers and Clinical Trial Consent
This week we’ve narrowed our hot topics down to 2 articles about careers in the industry plus an article explaining revisions to the 16 year old FDA consent policies guide. 1. Great news for the CRO industry, a new report shows CROs are seeing high job growth! 2. If you are seeking a future in […]
This Week We’re Talking About: Elderly in Clinical Trials, an eTMF, and CRA Roles
Not to “toot our own horn”, but our much anticipated blog article, leads our list of hot topics this week! It is the 2nd in our series of articles examining critical issues concerning clinical trial participation and discusses the need for seniors in clinical trials. 1. Lack of Elderly Participation in Clinical Trials The 2nd article of […]
Lack of Elderly Participation in Clinical Trials
Clinical Trial Participation Part 2: The second of an ongoing series of articles examining critical issues concerning clinical trial participation Lack of Elderly Participation in Clinical Trials In part two of this ongoing series, we turn to the issue of the lack of elderly participation in clinical trials. According to the Administration on Aging, there […]